Showing results (2511-2520 of 3,088) with videos related to
Sort By:
Pageof 309
Drug Safety|July 8, 2021
Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort StudyVeena Hoffman, Jesper Hallas, Marie Linder, et al.Drug Safety|May 24, 2022
Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting SystemAnna Gaimari, Michele Fusaroli, Emanuel Raschi, et al.Drug Safety|May 17, 2022
Artificial Intelligence in Pharmacovigilance: An Introduction to Terms, Concepts, Applications, and LimitationsJeffrey K AronsonDrug Safety|May 17, 2022
Applying Machine Learning in Distributed Data Networks for Pharmacoepidemiologic and Pharmacovigilance Studies: Opportunities, Challenges, and ConsiderationsJenna Wong, Daniel Prieto-Alhambra, Peter R Rijnbeek, et al.Drug Safety|May 17, 2022
Identifying and Mitigating Potential Biases in Predicting Drug ApprovalsQingyang Xu, Elaheh Ahmadi, Alexander Amini, et al.Drug Safety|May 17, 2022
Automated Drug Coding Using Artificial Intelligence: An Evaluation of WHODrug Koda on Adverse Event ReportsEva-Lisa Meldau, Shachi Bista, Emma Rofors, et al.Drug Safety|May 17, 2022
Supervised Machine Learning-Based Decision Support for Signal Validation ClassificationMuhammad Imran, Aasia Bhatti, David M King, et al.Drug Safety|July 23, 2021
Use of Primary Care Data in Research and Pharmacovigilance: Eight Scenarios Where Prescription Data are AbsentGrace N Okoli, Puja Myles, Tarita Murray-Thomas, et al.Drug Safety|November 5, 1997
Pharmacological importance of stereochemical resolution of enantiomeric drugsM R Islam, J G Mahdi, I D BowenDrug Safety|November 5, 1997
Drug-induced uveitis. Incidence, prevention and treatmentF W Fraunfelder, J T RosenbaumPageof 309